Furthermore, the prognostic implication of PRDM16 expression have primarily been investigated in smaller cohorts of adult AML patients (n = 121, 151, 267) [15–17] or in pediatric AML [18, 23]. The gene discussed is PRDM16; the disease is acute myeloid leukemia.